- $2.83bn
- $3.55bn
- $821.38m
- 73
- 51
- 92
- 84
R2019 December 31st | R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 61 | 416 | 388 | 695 | 821 |
Cost of Revenue | |||||
Gross Profit | 56.9 | 307 | 381 | 672 | 818 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 621 | 1,055 | 444 | 741 | 456 |
Operating Profit | -560 | -638 | -56 | -46.7 | 366 |
Net Income Before Taxes | -560 | -638 | -56 | -46.7 | 366 |
Provision for Income Taxes | |||||
Net Income After Taxes | -549 | -591 | -34.5 | -59.8 | 366 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,049 | -2,676 | -310 | -322 | 185 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1,152 | -2,751 | -386 | -382 | 130 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.08 | -4.12 | 3.26 | -1.19 | 1.16 |
Dividends per Share |